Abstract: In the past decade, elevated levels of plasma homocysteine have emerged as a potential risk factor for vascular disease. Homocysteine is central in the metabolism of multiple vitamins, including cobalamin and folic acid. There are many reasons for elevated homocysteine levels, but folate deficiency is the most common, even in developed countries. Prospective studies correlating risk of heart disease and homocysteine have provided conflicting data. Data are stronger for the risk of cerebrovascular disease being related to high homocysteine concentrations. Therapy for most patients involves vitamin replacement. Early trial data indicate that lowering of homocysteine may reduce vascular complications.
Publication Year: 2002
Publication Date: 2002-06-01
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
Cited By Count: 2
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot